apoA-I Antibodies

Santa Cruz Biotechnology provides a broad selection of apoA-I monoclonal antibodies for research in understanding apolipoprotein A-I's role in lipid metabolism and cardiovascular health. ApoA-I monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Apolipoprotein A-I is a key component of high-density lipoprotein (HDL) and plays a crucial role in cholesterol transport and reverse cholesterol metabolism. Research has shown that apolipoprotein A-I maintains lipid homeostasis and contributes significantly to preventing atherosclerosis and cardiovascular diseases. Understanding apolipoprotein A-I function opens new possibilities for developing therapeutic strategies aimed at improving cardiovascular health. Researchers worldwide use apoA-I monoclonal antibodies to investigate cellular pathways involved in lipid metabolism. Current studies focus on how apolipoprotein A-I influences HDL formation and function in various physiological conditions. Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance our understanding of cardiovascular health and disease prevention.